SMITHKLINE BEECHAM, SANDOZ PRODUCTS RESTRICTED TO PRIOR APPROVAL UNDER MEDI-CAL FOR REFUSAL TO PAY REBATE; ANTIBIOTIC THERAPIES REVIEW PLANNED
Executive Summary
Medi-Cal will require prior authorization of SmithKline Beecham and Sandoz products under a recent decision stemming from the companies' refusal to pay supplemental rebates to the California Medicaid agency.